Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study. [PDF]
Ohtsuki M +8 more
europepmc +1 more source
Post-market surveillance of antiretroviral drug quality in Tanzania in the context of rising HIV drug resistance. [PDF]
Mlugu EM +11 more
europepmc +1 more source
Applied intelligence in clinical drug development: Potential benefits and emerging concerns. [PDF]
Bhatt A.
europepmc +1 more source
Risk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan. [PDF]
Yuri A +7 more
europepmc +1 more source
Comprehensive post-marketing safety evaluation of atezolizumab: A disproportionality analysis based on individual case safety reports in the FAERS. [PDF]
Cui Y +5 more
europepmc +1 more source
Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis. [PDF]
Han XY +5 more
europepmc +1 more source
Re-emergence of COVID-19 and preparedness. [PDF]
Choudhary G, Rajput H, Medhi B.
europepmc +1 more source
Pragmatic implementation of intravascular lithotripsy in Japan based on the guidelines for proper use. [PDF]
Shiba T +6 more
europepmc +1 more source
Post-market surveillance of albendazole tablet brands in Kenya: Implications for deworming programs and clinical outcomes. [PDF]
Yator EK, Njogu PM.
europepmc +1 more source
Clinical research in pediatric population: Scientific and ethical aspects. [PDF]
Bhatt A.
europepmc +1 more source

